School of Medicine

School of Medicine scientists have developed a compound that prevents SARS-CoV-2 and related coronaviruses from entering cells. The researchers are collaborating with the NIH to test the compound in animal models of COVID-19.

Matthew A. Cruz, a predoctoral scholar in biochemistry and molecular biophysics and in the laboratory of Gregory Bowman at the School of Medicine, received a three-year $95,910 fellowship award from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH).

As artificial intelligence becomes more incorporated into the medical field, rigorous evaluation of these methods is needed before they are introduced into clinical practice, a team led by Washington University researchers Abhinav Jha and Barry Siegel, MD, proposed.

The National Institute of Mental Health has awarded James Fitzpatrick a $600,000 grant to purchase a cutting-edge optical microscope for the Washington University Center for Cellular Imaging, expanding super-resolution imaging to a broader range of wavelengths.

Jhullian Jamille Alston, a predoctoral trainee in biochemistry and molecular biophysics and in the laboratories of Alex Holehouse and Andrea Soranno at the School of Medicine, received a predoctoral-to-postdoctoral fellow transition award from the National Cancer Institute of the National Institutes of Health (NIH).

The National Institute of Mental Health has awarded Washington University School of Medicine a $12.2 million grant to create a center aimed at advancing research into neurosteroids as treatments for depression and other psychiatric disorders.

Meaghan Creed, assistant professor of anesthesiology at Washington University School of Medicine, received the 2021 Freedman Prize from the Brain & Behavior Research Foundation. The prize recognizes exceptional basic research in mental illness.

A pediatric COVID-19 vaccine clinical trial is underway in St. Louis. Led by Washington University School of Medicine, about 140 area children will receive the two-shot Moderna vaccine or a placebo at St. Louis Children’s Hospital as part of a clinical trial involving about 100 medical institutions in the U.S. and Canada.

Researchers at Washington University School of Medicine, the Mayo Clinic in Rochester, Minn., and The Neuro of McGill University have received a five-year grant expected to total $35.1 million for an extension of a study designed to develop biomarkers that indicate which people with REM sleep behavior disorder will go on to develop neurodegenerative diseases.

BJC HealthCare soon will break ground on a 16-story inpatient hospital tower at Barnes-Jewish Hospital. The new tower is an important component of BJC’s Campus Renewal, a long-term vision to transform the Medical Campus to improve the experiences of patients and families.